VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

about

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

Item

http://www.wikidata.org/entity/Q37301542

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

@en

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions.

@nl

type

Item

label

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

@en

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions.

@nl

prefLabel

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

@en

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions.

@nl

P1476

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

@en

P2093

A Bazani

http://www.w3.org/2001/XMLSchema#string

A Ferrari

http://www.w3.org/2001/XMLSchema#string

A Surgo

http://www.w3.org/2001/XMLSchema#string

B A Jereczek-Fossa

http://www.w3.org/2001/XMLSchema#string

C Fodor

http://www.w3.org/2001/XMLSchema#string

C Garibaldi

http://www.w3.org/2001/XMLSchema#string

D Ciardo

http://www.w3.org/2001/XMLSchema#string

D Maestri

http://www.w3.org/2001/XMLSchema#string

F Golino

http://www.w3.org/2001/XMLSchema#string

F Pansini

http://www.w3.org/2001/XMLSchema#string

P2860

Review and uses of stereotactic body radiation therapy for oligometastases

Stereotactic body radiotherapy for oligometastases.

Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases.

Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.

Solitary metastases: illusion versus reality.

Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.

The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far?

Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review.

Stereotactic body radiotherapy for prostate cancer.

Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer.

P304

677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3332/ECANCER.2016.677

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27729942

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5045299

http://www.w3.org/2001/XMLSchema#string